Phase 1 Open-label Study of 123I-ATT001 in Subjects With Relapsed Glioblastoma

Clinical trial NCT06650605 · COMPLETED

Trial details

NCT number: NCT06650605
Sponsor: Theragnostics Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma Glioblastoma Multiforme

Start date: 2024-07-04
Primary completion: 2026-03-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.